carvedilol has been researched along with Acne Rosacea in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rosacea, a chronic inflammatory skin disorder etiologically associated with immune cells and the antibacterial peptide cathelicidin LL-37, can be effectively treated by oral carvedilol administration." | 8.02 | A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages. ( Hu, L; Jiang, P; Li, M; Liu, W; Liu, Y; Sheng, L; Tao, M; Wang, X; Xu, Y; Yang, Y; Zhang, J, 2021) |
| "These findings demonstrate that facial flushing and persistent erythema can be effectively treated by carvedilol long-term with a fast onset of improvement in a dose well tolerated." | 7.88 | Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol. ( Pietschke, K; Schaller, M, 2018) |
| " Clinician's erythema assessment (CEA) and Demodex density were evaluated before and after topical ivermectin alone or combined with oral carvedilol." | 5.62 | Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol. ( Hsu, CK; Huang, HP; Lee, JY, 2021) |
| "Flushing and erythema are the most common symptoms of rosacea; however, management of these symptoms remains challenging." | 5.56 | Facial flushing and erythema of rosacea improved by carvedilol. ( Choi, YS; Kim, DH; Seo, BH; Suh, HS, 2020) |
| "Rosacea, a chronic inflammatory skin disorder etiologically associated with immune cells and the antibacterial peptide cathelicidin LL-37, can be effectively treated by oral carvedilol administration." | 4.02 | A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages. ( Hu, L; Jiang, P; Li, M; Liu, W; Liu, Y; Sheng, L; Tao, M; Wang, X; Xu, Y; Yang, Y; Zhang, J, 2021) |
| "These findings demonstrate that facial flushing and persistent erythema can be effectively treated by carvedilol long-term with a fast onset of improvement in a dose well tolerated." | 3.88 | Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol. ( Pietschke, K; Schaller, M, 2018) |
| "Flushing and erythema are frequent skin symptoms in rosacea." | 2.66 | Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action. ( Driessen, RJB; Logger, JGM; Olydam, JI, 2020) |
| " Clinician's erythema assessment (CEA) and Demodex density were evaluated before and after topical ivermectin alone or combined with oral carvedilol." | 1.62 | Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol. ( Hsu, CK; Huang, HP; Lee, JY, 2021) |
| "Flushing and erythema are the most common symptoms of rosacea; however, management of these symptoms remains challenging." | 1.56 | Facial flushing and erythema of rosacea improved by carvedilol. ( Choi, YS; Kim, DH; Seo, BH; Suh, HS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Tang, JY | 1 |
| Fu, J | 1 |
| Zhang, MW | 1 |
| Wan, M | 1 |
| Chen, DW | 1 |
| Chen, QQ | 1 |
| Li, X | 1 |
| Song, GJ | 1 |
| Ni, RR | 1 |
| Song, ZQ | 1 |
| Logger, JGM | 1 |
| Olydam, JI | 1 |
| Driessen, RJB | 1 |
| Chalhoub, G | 1 |
| Ayoub, N | 1 |
| Seo, BH | 1 |
| Kim, DH | 1 |
| Suh, HS | 1 |
| Choi, YS | 1 |
| Huang, HP | 1 |
| Hsu, CK | 1 |
| Lee, JY | 4 |
| Zhang, J | 1 |
| Jiang, P | 1 |
| Sheng, L | 1 |
| Liu, Y | 2 |
| Li, M | 1 |
| Tao, M | 1 |
| Hu, L | 1 |
| Wang, X | 1 |
| Yang, Y | 1 |
| Xu, Y | 1 |
| Liu, W | 1 |
| Lee, CN | 1 |
| Pietschke, K | 1 |
| Schaller, M | 1 |
| Hsu, CC | 2 |
1 review available for carvedilol and Acne Rosacea
| Article | Year |
|---|---|
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; Carvedilol; Dermatologic Agents; Dru | 2020 |
1 trial available for carvedilol and Acne Rosacea
| Article | Year |
|---|---|
Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression.
Topics: Adult; Anxiety; Brimonidine Tartrate; Carvedilol; Depression; Erythema; Humans; Rosacea | 2022 |
8 other studies available for carvedilol and Acne Rosacea
| Article | Year |
|---|---|
[Treatment of social craniofacial flushing with carvedilol].
Topics: Carvedilol; Flushing; Humans; Rosacea; Treatment Outcome | 2020 |
Facial flushing and erythema of rosacea improved by carvedilol.
Topics: Carvedilol; Erythema; Flushing; Humans; Retrospective Studies; Rosacea; Treatment Outcome | 2020 |
Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol.
Topics: Carvedilol; Erythema; Humans; Ivermectin; Retrospective Studies; Rosacea | 2021 |
A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
Topics: Animals; Anti-Inflammatory Agents; Antimicrobial Cationic Peptides; Carvedilol; Cathelicidins; Cytok | 2021 |
Severe erythematotelangiectatic rosacea with cold wave-induced epidermal necrosis treated with carvedilol combined with brimonidine gel.
Topics: Administration, Cutaneous; Brimonidine Tartrate; Carbazoles; Carvedilol; Cold Temperature; Dermatolo | 2017 |
Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Erythema; Female; Flushing; Humans; Midd | 2018 |
Carvedilol for the treatment of refractory facial flushing and persistent erythema of rosacea.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Erythema; Female; Flushing; Humans; Middle Aged | 2011 |
Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective β-adrenergic blocker.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Female; Flushing; Humans; Ma | 2012 |